Wada Satoshi

Researcher

基本情報

Profile and Settings

• 氏名

  Wada Satoshi

Affiliation

• Clinical Research Institute for Clinical Pharmacology and Therapeutics: Clinical Oncology Diagnostics, Professor

Location

• Karasuyama Hospital

Degree

• Doctor of Medical Science, Gunma University, May 2005

Achievements

Published Papers

• 高密度レクチンアレイを用いた腫瘍抗原における糖鎖構造の解明, 和田　聡, 昭和学士会雑誌, 84(1):75 - 81, Mar. 2024, Peer-reviewed, DOI:https://doi.org/10.14930/jshowaunivsoc.84.75
• Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors., Ohkuma R, Miura S, Muto S, Toyomasu Y, Fujimoto Y, Ieguchi K, Onishi N, Shimizu T, Watanabe M, Takayanagi D, Goshima T, Horiike A, Hamada K, Ariizumi H, Shimokawa M, Hirasawa Y, Ishiguro T, Suzuki R, Iriguchi N, Tsurui T, Mura E, Takenoshita S, Numajiri K, Okabe N, Yoshimura K, Tsuji M, Kiuchi Y, Yajima T, Ishida H, Suzuki H, Yamochi T, Kobayashi S, Tsunoda T, Wada S., Front Immunol, 14:1260492, Sep. 2023, Peer-reviewed, DOI:10.3389/fimmu.2023.1260492
• Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor., Hamada Kazuyuki;Isobe Junya;Hattori Kouya;Hosonuma Masahiro;Baba Yuta;Murayama Masakazu;Narikawa Yoichiro;Toyoda Hitoshi;Funayama Eiji;Tajima Kohei;Shida Midori;Hirasawa Yuya;Tsurui Toshiaki;Ariizumi Hirotsugu;Ishiguro Tomoyuki;Suzuki Risako;Ohkuma Ryotaro;Kubota Yutaro;Sambe Takehiko;Tsuji Mayumi;Wada Satoshi;Kiuchi Yuji;Kobayashi Shinichi;Kuramasu Atsuo;Horiike Atsushi;Kim Yun-Gi;Tsunoda Takuya;Yoshimura Kiyoshi, Frontiers in immunology, 14:1164724, May 2023, DOI:10.3389/fimmu.2023.1164724
• The Sympathetic Nervous System Contributes to the Establishment of Pre-Metastatic Pulmonary Microenvironments., Ieguchi Katsuaki;Funakoshi Masabumi;Mishima Taishi;Takizawa Kohtaro;Omori Tsutomu;Nakamura Fumio;Watanabe Makoto;Tsuji Mayumi;Kiuchi Yuji;Kobayashi Shinichi;Tsunoda Takuya;Maru Yoshiro;Wada Satoshi, International journal of molecular sciences, 23(18):10652, Sep. 2022, DOI:10.3390/ijms231810652
• 腫瘍細胞の糖鎖構造に着目した新規がん免疫療法の開発, 和田 聡;家口 勝昭;大熊 遼太郎;高柳 大輔;角田 卓也;小林 真一, 臨床薬理の進歩, (43):98 - 108, Jun. 2022
• 【腫瘍免疫-免疫ネットワークから考える基礎と臨床】免疫チェックポイント阻害薬の成功から続く展望　新規がん免疫治療薬の開発　基礎研究と臨床応用への谷間をつなぐ橋渡し研究の重要性, 和田 聡;玉田 耕治, 医学のあゆみ, 281(5):543, Apr. 2022
• FGFR2 loss sensitizes MYCN-amplified neuroblastoma CHP134 cells to CHK1 inhibitor-induced apoptosis., Kiyohiro Ando; Miki Ohira; Ichiro Takada; Verna Cázares-Ordoñez; Yusuke Suenaga; Hiroki Nagase; Shinichi Kobayashi; Tsugumichi Koshinaga; Takehiko Kamijo; Makoto Makishima; Satoshi Wada, Cancer science, 113(2):587 - 596, Feb. 2022, Peer-reviewed, DOI:10.1111/cas.15205
• A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report., Hamada Kazuyuki;Yoshimura Kiyoshi;Oshinomi Kazuhiko;Hirasawa Yuya;Ariizumi Hirotsugu;Ohkuma Ryotaro;Shida Midori;Kubota Yutaro;Matsui Hiroto;Ishiguro Tomoyuki;Sambe Takehiko;Ishida Hiroo;Horiike Atsushi;Wada Satoshi;Iwamoto Sanju;Uchida Naoki;Ogawa Yoshio;Kobayashi Shinichi;Tsunoda Takuya, Medicine, 101(2):e28339, Jan. 2022, DOI:10.1097/MD.0000000000028339
• Antibiotic Usage Reduced Overall Survival by over 70% in Non-small Cell Lung Cancer Patients on Anti-PD-1 Immunotherapy., Kazuyuki Hamada; Kiyoshi Yoshimura; Yuya Hirasawa; Masahiro Hosonuma; Masakazu Murayama; Yoichiro Narikawa; Hirotsugu Ariizumi; Ryotaro Ohkuma; Midori Shida; Yutaro Kubota; Satoshi Matsukuma; Tomoyuki Ishiguro; Takehiko Sambe; Atsushi Horiike; Atsuo Kuramasu; Satoshi Wada; Junji Tsurutani; Eisuke Inoue; Naoki Uchida; Yuji Kiuchi; Shinichi Kobayashi; Robert M Hoffman; Takuya Tsunoda, Anticancer research, 41(10):4985 - 4993, Oct. 2021
• 肝胆膵がんに対する薬物療法の最前線, 和田　聡, 昭和学士会雑誌, 81(3):154 - 161, Aug. 2021, Peer-reviewed
• A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy., Yuya Hirasawa; Kiyoshi Yoshimura; Hiroto Matsui; Yutaro Kubota; Hiroo Ishida; Jun Arai; Masashi Sakaki; Nao Oguro; Midori Shida; Makoto Taniguchi; Kazuyuki Hamada; Hirotsugu Ariizumi; Tomoyuki Ishiguro; Ryotaro Ohkuma; Takehiko Sambe; Atsushi Horiike; Chiyo K Imamura; Eisuke Shiozawa; Satoshi Wada; Junji Tsurutani; Sanju Iwamoto; Naoki Uchida; Yuji Kiuchi; Genshu Tate; Shinichi Kobayashi; Takuya Tsunoda, Medicine, 100(23):e25774, Jun. 2021
• Rare nivolumab-associated super hyper progressive disease in patients with advanced gastric cancer, Yutaro Kubota; Kiyoshi Yoshimura; Kazuyuki Hamada; Yuya Hirasawa; Midori Shida; Makoto Taniguchi; Hiroto Matsui; Hirotsugu Ariizumi; Tomoyuki Ishiguro; Norihiro Suzuki; Ryotaro Ohkuma; Takehiko Sambe; Hiroo Ishida; Atsushi Horiike; Satoshi Wada; Junji Tsurutani; Sanju Iwamoto; Naoki Uchida; Yuji Kiuchi; Shinichi Kobayashi; Takuya Tsunoda, In Vivo, 35(3):1865 - 1875, May 2021
• Analysis of ADAM12-Mediated Ephrin-A1 Cleavage and Its Biological Functions, IEGUCHI Katsuaki;TOMITA Takeshi;TAKAO Toshifumi;OMORI Tsutomu;MISHIMA Taishi;SHIMIZU Isao;TOGNOLINI Massimiliano;LODOLA Alessio;TSUNODA Takuya;KOBAYASHI Shinichi;WADA Satoshi;MARU Yoshiro, Int J Mol Sci, 22(5):2480, Mar. 2021, Peer-reviewed
• The Prognostic Impact of Eosinophils and the Eosinophil-to-Lymphocyte Ratio on Survival Outcomes in Stage II Resectable Pancreatic Cancer., Ryotaro Ohkuma; Yutaro Kubota; Atsushi Horiike; Tomoyuki Ishiguro; Yuya Hirasawa; Hirotsugu Ariizumi; Makoto Watanabe; Rie Onoue; Kiyohiro Ando; Junji Tsurutani; Kiyoshi Yoshimura; Takeshi Aoki; Masahiko Murakami; Shinichi Kobayashi; Takuya Tsunoda; Satoshi Wada, Pancreas, 50(2):167 - 175, Feb. 2021
• A high number of PD-L1+ CD14+ monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitors., Kiyohiro Ando; Kazuyuki Hamada; Midori Shida; Ryotaro Ohkuma; Yutaro Kubota; Atsushi Horiike; Hiroto Matsui; Tomoyuki Ishiguro; Yuya Hirasawa; Hirotsugu Ariizumi; Makoto Watanabe; Rie Onoue; Junji Tsurutani; Kiyoshi Yoshimura; Takuya Tsunoda; Shinichi Kobayashi; Satoshi Wada, Cancer immunology, immunotherapy : CII, 70(2):337 - 348, Feb. 2021
• High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer., Ryotaro Ohkuma; Erica Yada; Shumpei Ishikawa; Daisuke Komura; Yutaro Kubota; Kazuyuki Hamada; Atsushi Horiike; Tomoyuki Ishiguro; Yuya Hirasawa; Hirotsugu Ariizumi; Midori Shida; Makoto Watanabe; Rie Onoue; Kiyohiro Ando; Junji Tsurutani; Kiyoshi Yoshimura; Tetsuro Sasada; Takeshi Aoki; Masahiko Murakami; Tomoko Norose; Nobuyuki Ohike; Masafumi Takimoto; Shinichi Kobayashi; Takuya Tsunoda; Satoshi Wada, International journal of oncology, 58(1):57 - 69, Jan. 2021
• [Current Status of Biomarkers in the Use of Immune Checkpoint Inhibitors]., Satoshi Wada, Gan to kagaku ryoho. Cancer & chemotherapy, 47(9):1298 - 1302, Sep. 2020
• High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancer., Ryotaro Ohkuma; Erica Yada; Shumpei Ishikawa; Daisuke Komura; Yutaro Kubota; Kazuyuki Hamada; Atsushi Horiike; Tomoyuki Ishiguro; Yuya Hirasawa; Hirotsugu Ariizumi; Midori Shida; Makoto Watanabe; Rie Onoue; Kiyohiro Ando; Junji Tsurutani; Kiyoshi Yoshimura; Tetsuro Sasada; Takeshi Aoki; Masahiko Murakami; Tomoko Norose; Nobuyuki Ohike; Masafumi Takimoto; Shinichi Kobayashi; Takuya Tsunoda; Satoshi Wada, Oncology reports, 44(1):252 - 262, Jul. 2020
• High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer., OHKUMA Ryotaro;YADA Erica;ISHIKAWA Shumpei;KOMURA Daisuke;ISHIZAKI Hidenobu;TAMADA Koji;KUBOTA Yutaro;HAMADA Kazuyuki;ISHIDA Hiroo;HIRASAWA Yuya;ARIIZUMI Hirotsugu;SATOH Etsuko;SHIDA Midori;WATANABE Makoto;ONOUE Rie;ANDO Kiyohiro;TSURUTANI Junji;YOSHIMURA Kiyoshi;YOKOBORI Takehiko;SASADA Tetsuro;AOKI Takeshi;MURAKAMI Masahiko;NOROSE Tomoko;OHIKE Nobuyuki;TAKIMOTO Masafumi;IZUMIZAKI Masahiko;KOBAYASHI Shinichi;TSUNODA Takuya;WADA Satoshi, PloS One, 15(1):e0226707, Jan. 2020, Peer-reviewed
• CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma., Kiyohiro Ando; Verna Cázares-Ordoñez; Makoto Makishima; Atsushi Yokoyama; Yusuke Suenaga; Hiroki Nagase; Shinichi Kobayashi; Takehiko Kamijo; Tsugumichi Koshinaga; Satoshi Wada, Journal of oncology, 2020:2752417 - 2752417, 2020
• MDM2 Increase Sensitivity to CHK1 Inhibitor Through the Interaction Between p53 and Centrosome-Associated Family Protein in Neuroblasotma, Kiyohiro Ando; Verna Cazares; Hide Kaneda; Syuichiro Uehara; Makoto Makishima; Hiroki Nagase; Tsugumichi Koshinaga; Satoshi Wada, PEDIATRIC BLOOD & CANCER, 66:S105 - S105, Dec. 2019
• Eosinophilic bronchiolitis successfully treated with mepolizumab., Takeshita Yuichiro;Nobuyama Seiichi;Kanetsuna Yukiko;Tanaka Akihiko;Adachi Mitsuru;Sato Tetsuo;Tada Yuji, The journal of allergy and clinical immunology. In practice, 8(3), Oct. 2019
• Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial, SHIMIZU Yasuhiro;YOSHIKAWA Toshiaki;KOJIMA Takashi;SHODA Kayoko;NOSAKA Kazuto;MIZUNO Shoichi;WADA Satoshi;FUJIMOTO Yuki;SASADA Tetsuro;KOHASHI Kenichi;BANDO Hideaki;ENDO Itaru;NAKATSURA Tetsuya, Cancer Sci, 110(10):3049 - 3060, Oct. 2019, Peer-reviewed
• Current Status and Prospect of biomarker in immune checkpoint inhibitors, 和田　聡, 日本免疫治療学会誌, (7):1 - 8, Oct. 2019, Peer-reviewed
• Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With Lung and Gastric Cancer Treated With Immune Checkpoint Inhibitors, ANDO Kiyohiro;HAMADA Kazuyuki;WATANABE Makoto;OHKUMA Ryotaro;SHIDA Midori;ONOUE Rie;KUBOTA Yutaro;MATSUI Hiroto;ISHIGURO Tomoyuki;HIRASAWA Yuya;ARIIZUMI Hirotsugu;TSURUTANI Junji;YOSHIMURA Kiyoshi;TSUNODA Takuya;KOBAYASHI Shinichi;WADA Satoshi, Anticancer Res, 39(9):5195 - 5201, Sep. 2019, Peer-reviewed
• Progress and future direction of cancer immunotherapy, 和田　聡;玉田　耕治, 腫瘍内科, 24(3):215 - 222, Sep. 2019
• Immunohistological analysis of pancreatic carcinoma after vaccination with survivin 2B peptide: analysis of an autopsy series, KUBO Terufumi;TSURITA Giichiro;HIROHASHI Yoshihiko;YASUI Hiroshi;OTA Yasunori;WATANABE Kazue;MURAI Aiko;MATSUO Kazuhiko;ASANUMA Hiroko;SHIMA Hiroaki;WADA Satoshi;NAKATSUGAWA Munehide;KANASEKI Takayuki;TSUKAHARA Tomohide;MIZUGUCHI Toru;HIRATA Koichi;TAKEMASA Ichiro;IMAI Kohzoh;SATO Noriyuki;TORIGOE Toshihiko, Cancer Sci, 110(8):2386 - 2395, Aug. 2019, Peer-reviewed
• Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA-A24–positive pancreatic adenocarcinoma, SHIMA Hiroaki;TSURITA Giichiro;WADA Satoshi;HIROHASHI Yoshihiko;YASUI Hiroshi;HAYASHI Hiroshi;MIYAKOSHI Takashi;WATANABE Kazue;MURAI Aiko;ASANUMA Hiroko;TOKITA Serina;KUBO Terufumi;NAKATSUGAWA Munehide;KANASEKI Takayuki;TSUKAHARA Tomohide;NAKAE Yutaka;SUGITA Osamu;ITO Yoichi M;OTA Yasunori;KIMURA Yasutoshi;KUTOMI Goro;HIRATA Koichi;MIZUGUCHI Toru;IMAI Kohzoh;TAKEMASA Ichiro;SATO Noriyuki;TORIGOE Toshihiko, Cancer Sci, 110(8):2378 - 2385, Aug. 2019, Peer-reviewed
• High expression of Olfactomedin-4 correlates with chemoresistance and poor prognosis for pancreatic cancer, Ryotaro Ohkuma; Erica Yada; Yutaro Kubota; Kazuyuki Hamada; Hiroo Ishida; Yuya Hirasawa; Hirotsugu Ariizumi; Etsuko Satoh; Junji Tsurutani; Kiyoshi Yoshimura; Tetsuro Sasada; Takeshi Aoki; Masahiko Murakami; Tomoko Norose; Nobuyuki Ohike; Masafumi Takimoto; Takuya Tsunoda; Satoshi Wada, CANCER RESEARCH, 79(13), Jul. 2019
• Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells, ANDO Kiyohiro;NAKAMURA Yohko;NAGASE Hiroki;NAKAGAWARA Akira;KOSHINAGA Tsugumichi;WADA Satoshi;MAKISHIMA Makoto, Int J Mol Sci, 20(15):E3700, Jul. 2019, Peer-reviewed
• 癌免疫サイクルと免疫編集, 和田　聡, 消化器外科, 42(8):1231 - 1236, Jul. 2019
• Immunologic efficacy of heat shock protein 105 peptide vaccine in patients with advanced colorectal and esophageal cancer, Yasuhiro Shimizu; Toshiaki Yoshikawa; Kojima Takashi; Kayoko Shoda; Kazuto Nosaka; Shoichi Mizuno; Satoshi Wada; Yuki Fujimoto; Tetsuro Sasada; Kenichi Kohashi; Hideaki Bando; Itaru Endo; Tetsuya Nakatsura, CANCER IMMUNOLOGY RESEARCH, 7(2), Feb. 2019
• がん免疫療法の歴史, 和田　聡, 日本医師会雑誌, 147(11):2224 - 2228, Feb. 2019
• Immunohistological analysis of pancreatic carcinoma after vaccination with survivin 2B peptide: Analysis of an autopsy series, T. Kubo; G. Tsurita; Y. Hirohashi; H. Yasui; Y. Ota; K. Watanabe; A. Murai; K. Matsuo; H. Asanuma; H. Shima; S. Wada; M. Nakatsugawa; T. Kanaseki; T. Tsukahara; T. Mizuguchi; K. Hirata; I. Takemasa; K. Imai; N. Sato; T. Torigoe, Sapporo Medical journal, 88(1-6):80 - 81, Dec. 2018
• Identification of therapeutic-specific mutations induced by anti-cancer drug using pancreatic cancer xenograft, Erica Yada; Tetsuro Sasada; Satoshi Wada, CANCER SCIENCE, 109:948 - 948, Dec. 2018
• What is the checkpoint of the immunotherapy against GI cancer?, Kiyoshi Yoshimura; Satoshi Wada; Takuya Tsunoda, CANCER SCIENCE, 109:371 - 371, Dec. 2018
• Enhanced expression of PD-L1 in non-muscle-invasive bladder cancer after treatment with Bacillus Calmette-Guerin, HASHIZUME Akihito;UMEMOTO Susumu;YOKOSE Tomoyuki;NAKAMURA Yoshiyasu;YOSHIHARA Mitsuyo;SHOJI Kahori;WADA Satoshi;MIYAGI Yohei;KISHIDA Takeshi;SASADA Tetsuro, Oncotarget, 9(75):34066 - 34078, Sep. 2018, Peer-reviewed
• Elucidation of immunosuppressive microenvironment in colorectal cancer, Tetsuro Sasada; Junya Ohtake; Tetsuta Satoyoshi; Keisuke Kazama; Satoshi Wada; Erika Yada; Manabu Shiozawa, CANCER RESEARCH, 78(13), Jul. 2018
• Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer, TSUKAGOSHI Mariko;WADA Satoshi;HIRONO Seiko;YOSHIDA Shintaro;YADA Erica;SASADA Tetsuro;SHIRABE Ken;KUWANO Hiroyuki;YAMAUE Hiroki, Oncotarget, 9(59):31448 - 31458, Jul. 2018, Peer-reviewed
• Present and future of immune checkpoint inhibitors, 和田　聡;吉村　清, 臨床免疫・アレルギー科, 69(6):531 - 538, Jun. 2018
• Use of patient-derived xenograft mouse models in cancer research and treatment, Erica Yada; Satoshi Wada; Shintaro Yoshida; Tetsuro Sasada, FUTURE SCIENCE OA, 4(3):FSO271, Mar. 2018
• Elucidation of potential immune suppressive mechanisms in colorectal cancer, Junya Ohtake; Tetsuta Satoyoshi; Satoshi Wada; Erica Yada; Hiromi Mikami; Shintaro Yoshida; Manabu Shiozawa; Tetsuro Sasada, CANCER SCIENCE, 109:674 - 674, Jan. 2018
• Analysis of gemcitabine (GEM) resistant mechanism using pancreatic cancer patient-derived xenograft (PDX) model, Erica Yada; Junya Ohtake; Tetsuro Sasada; Satoshi Wada, CANCER SCIENCE, 109:176 - 176, Jan. 2018
• Expression levels of UL16 binding protein 1 and natural killer group 2 member D affect overall survival in patients with gastric cancer following gastrectomy, Ryoji Kamei; Kiyoshi Yoshimura; Shigefumi Yoshino; Moeko Inoue; Tetsuhiko Asao; Masanori Fuse; Satoshi Wada; Atsuo Kuramasu; Tomoko Furuya-Kondo; Atsunori Oga; Norio Iizuka; Nobuaki Suzuki; Noriko Maeda; Yusaku Watanabe; Satoshi Matsukuma; Michihisa Iida; Shigeru Takeda; Tomio Ueno; Noboru Yamamoto; Takeo Fukagawa; Hitoshi Katai; Hiroki Sasaki; Shoichi Hazama; Masaaki Oka; Hiroaki Nagano, ONCOLOGY LETTERS, 15(1):747 - 754, Jan. 2018
• Personalized peptide vaccines for cancer therapy: Current progress and state of the art, Satoshi Wada; Erica Yada; Junya Ohtake; Tetsuro Sasada, Expert Review of Precision Medicine and Drug Development, 2(6):371 - 381, Nov. 2017
• Correlation Between NKG2DL Expression and Antitumor Effect of Protein-bound Polysaccharide-K in Tumor-bearing Mouse Models, Ayano Konagai; Kiyoshi Yoshimura; Shouichi Hazama; Noboru Yamamoto; Kazunori Aoki; Tomio Ueno; Masaki Fujioka; Hiroko Iijima; Mariko Kato; Motoyuki Uchida; Tsutomu Wada; Moeko Inoue; Tetsuhiko Asao; Masanori Fuse; Satoshi Wada; Atsuo Kuramasu; Ryoji Kamei; Shigeru Takeda; Shigeru Yamamoto; Shigefumi Yoshino; Masaaki Oka; Hiroaki Nagano, ANTICANCER RESEARCH, 37(8):4093 - 4101, Aug. 2017
• Expression levels of UL16 binding protein 1 and natural killer group 2 member D in patients with gastric cancer, Kiyoshi Yoshimura; Moeko Inoue; Tetsuhiko Asao; Masanori Fuse; Satoshi Wada; Atsuo Kuramasu, CANCER RESEARCH, 77, Jul. 2017
• Comprehensive analysis of T cells responsive to neoantigens derived from tumor-specific genetic mutations, Tetsuro Sasada; Junya Ohtake; Satoshi Wada; Erika Yada; Shintaro Yoshida, CANCER RESEARCH, 77, Jul. 2017
• Analysis of the newly defined immune checkpoints in pancreatic cancer., Satoshi Wada, JOURNAL OF CLINICAL ONCOLOGY, 35(7), Mar. 2017
• Current status and future prospects of peptide-based cancer vaccines., Satoshi Wada; Erika Yada; Junya Ohtake; Yuki Fujimoto; Hidemi Uchiyama; Shintaro Yoshida; Tetsuro Sasada, Immunotherapy, 8(11):1321 - 1333, Nov. 2016
• Preclinical analysis of combination therapy using radiation and cellular immunotherapy, Satoshi Wada, CANCER RESEARCH, 76, Jul. 2016
• Development of combination therapy using radiation and cell-based immunotherapy, Satoshi Wada, JOURNAL OF CLINICAL ONCOLOGY, 34(15), May 2016
• Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma, Mariko Tsukagoshi; Satoshi Wada; Takehiko Yokobori; Bolag Altan; Norihiro Ishii; Akira Watanabe; Norio Kubo; Fumiyoshi Saito; Kenichiro Araki; Hideki Suzuki; Yasuo Hosouchi; Hiroyuki Kuwano, CANCER SCIENCE, 107(2):116 - 122, Feb. 2016
• A Resected Case of Mucinous Adenocarcinoma of the Duodenum, Mimicking Intraductal Papillary Neoplasm of the Bile Duct, Norio Kubo; Hideki Suzuki; Norihiro Ishii; Mariko Tsukagoshi; Akira Watanabe; Kenichiro Araki; Satoshi Wada; Wataru Wada; Yasushi Mochida; Fumiyoshi Saito; Hiroyuki Kuwano, INTERNATIONAL SURGERY, 100(11-12):1443 - 1448, Nov. 2015
• Aggressive Surgical Resection Combined With Imatinib Therapy for Liver Metastases From a Gastrointestinal Stromal Tumor, Mariko Tsukagoshi; Hideki Suzuki; Kenichiro Araki; Norihiro Ishii; Akira Watanabe; Norio Kubo; Satoshi Wada; Fumiyoshi Saito; Hiroyuki Kuwano, INTERNATIONAL SURGERY, 100(9-10):1295 - 1300, Sep. 2015
• Xanthogranulomatous cholecystitis: Difficulty in differentiating from gallbladder cancer, Hideki Suzuki; Satoshi Wada; Kenichiro Araki; Norio Kubo; Akira Watanabe; Mariko Tsukagoshi; Hiroyuki Kuwano, WORLD JOURNAL OF GASTROENTEROLOGY, 21(35):10166 - 10173, Sep. 2015
• Analysis of the immune suppression mechanism in extra-hepatic cholangiocarcinoma, Satoshi Wada; Mariko Tsukagoshi; Akira Watanabe; Norio Kubo; Kenichiro Araki; Hideki Suzuki; Hiroyuki Kuwano, CANCER RESEARCH, 75, Aug. 2015
• Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma, Hideki Suzuki; Mina Komuta; Altan Bolog; Takehiko Yokobori; Satoshi Wada; Kenichiro Araki; Norio Kubo; Akira Watanabe; Mariko Tsukagoshi; Hiroyuki Kuwano, DIGESTIVE AND LIVER DISEASE, 47(7):590 - 596, Jul. 2015
• Giant Cholangiolocellular Carcinoma With Early Recurrence That Was Difficult to Distinguish From Cholangiocellular Carcinoma: Report of a Case, Norihiro Ishii; Hideki Suzuki; Mariko Tsukagoshi; Akira Watanabe; Norio Kubo; Kenichiro Araki; Satoshi Wada; Hiroyuki Kuwano, INTERNATIONAL SURGERY, 100(6):1111 - 1116, Jun. 2015
• Clinicopathological implications of newly defined immune checkpoints in extra-hepatic cholangiocarcinoma, Satoshi Wada, JOURNAL OF CLINICAL ONCOLOGY, 33(15), May 2015
• 肝前上区域、後区域における腹腔鏡下肝切除アプローチの工夫, 新木 健一郎; 鈴木 秀樹; 石井 範洋; 塚越 真梨子; 渡辺 亮; 久保 憲生; 和田 聡; 桑野 博行, 日本消化器外科学会雑誌, 47(Suppl.2):200 - 200, Oct. 2014
• Extracapsular Lymph Node Involvement is Associated With Colorectal Liver Metastases and Impact Outcome After Hepatectomy for Colorectal Metastases, Hideki Suzuki; Takaaki Fujii; Takayuki Asao; Soichi Tsutsumi; Satoshi Wada; Kenichiro Araki; Norio Kubo; Akira Watanabe; Mariko Tsukagoshi; Hiroyuki Kuwano, WORLD JOURNAL OF SURGERY, 38(8):2079 - 2088, Aug. 2014
• Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma, Akira Watanabe; Hideki Suzuki; Takehiko Yokobori; Mariko Tsukagoshi; Bolag Altan; Norio Kubo; Shigemasa Suzuki; Kenichiro Araki; Satoshi Wada; Kenji Kashiwabara; Yasuo Hosouchi; Hiroyuki Kuwano, CANCER SCIENCE, 105(6):690 - 696, Jun. 2014
• To Stent or Not To Stent Hepaticojejunostomy - Analysis of Risk Factors for Postoperative Bile Leaks and Surgical Complication, Hideki Suzuki; Tatsuo Shimura; Yasushi Mochhida; Satoshi Wada; Kenichiro Araki; Norio Kubo; Akira Watanabe; Hiroyuki Kuwano, HEPATO-GASTROENTEROLOGY, 61(132):920 - 926, Jun. 2014
• Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis, Akira Watanabe; Hideki Suzuki; Takehiko Yokobori; Bolag Altan; Norio Kubo; Kenichiro Araki; Satoshi Wada; Yasushi Mochida; Shigeru Sasaki; Kenji Kashiwabara; Yasuo Hosouchi; Hiroyuki Kuwano, CANCER SCIENCE, 104(11):1427 - 1432, Nov. 2013
• Combined treatment effects of radiation and immunotherapy: studies in an autochthonous prostate cancer model., Satoshi Wada; Timothy J Harris; Erik Tryggestad; Kiyoshi Yoshimura; Jing Zeng; Hung-Rong Yen; Derese Getnet; Joseph F Grosso; Tullia C Bruno; Angelo M De Marzo; George J Netto; Drew M Pardoll; Theodore L DeWeese; John Wong; Charles G Drake, International journal of radiation oncology, biology, physics, 87(4):769 - 76, Nov. 2013
• Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer., Satoshi Wada; Christopher M Jackson; Kiyoshi Yoshimura; Hung-Rong Yen; Derese Getnet; Timothy J Harris; Monica V Goldberg; Tullia C Bruno; Joseph F Grosso; Nicholas Durham; George J Netto; Drew M Pardoll; Charles G Drake, Journal of translational medicine, 11(1):89 - 89, Apr. 2013
• Tumor-Associated Antigen Expressing Listeria monocytogenes Induces Effective Primary and Memory T-Cell Responses Against Hepatic Colorectal Cancer Metastases, Kelly Olino; Satoshi Wada; Barish H. Edil; Xiaoyu Pan; Kristen Meckel; Walter Weber; Jill Slansky; Koji Tamada; Peter Lauer; Dirk Brockstedt; Drew Pardoll; Richard Schulick; Kiyoshi Yoshimura, ANNALS OF SURGICAL ONCOLOGY, 19(SUPPL. 3):S597 - S607, Jul. 2012
• The intraductal injection of 5-fluorouracil for breast cancer: Preventive effect and immune response., Tsuyoshi Mori; Satoshi Wada; Kelly Olino; Barish H. Edil; Drew M. Pardoll; Richard D. Schulick; Saraswati Sukumar; Kiyoshi Yoshimura, JOURNAL OF CLINICAL ONCOLOGY, 30(15), May 2012
• The intraductal injection of 5-fluorouracil induces immune response to eradicate and prevent breast cancer, Tsuyoshi Mori; Satoshi Wada; Kelly Olino; Walter Weber; Barish Edil; Kristen Meckel; Xiaoyu Pan; Drew Pardoll; Richard Schulick; Saraswati Sukumar; Kiyoshi Yoshimura, CANCER RESEARCH, 71, Apr. 2011
• Modulation of immune checkpoint B7-H1/B7-DC/PD-1 interaction in combination with live attenuated Listeria monocytogenes expressing a tumor associated antigen effectively treats hepatic colorectal cancer metastases, Kiyoshi Yoshimura; Kelly Olino; Barish Edil; Satoshi Wada; Xiaoyu Pan; Kristen Meckel; Drew Pardoll; Richard Schulick, CANCER RESEARCH, 70, Apr. 2010
• Adoptive transfer of Tc17 CD8 T cells leads to tumor inhibition and anti-tumor response, Hung-Rong Yen; Timothy Harris; Vedran Radojcic; Dih-Dih Huang; Joseph Grosso; Derese Getnet; Satoshi Wada; Monica Goldberg; Tullia Bruno; Nicholas Durham; Khashayarsha Khazaie; Leo Luznik; Tzou-Yien Lin; Drew Pardoll; Ching-Tai Huang; Charles Drake, JOURNAL OF IMMUNOLOGY, 184, Apr. 2010
• A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells, Derese Getnet; Joseph F. Grosso; Monica V. Goldberg; Timothy J. Harris; Hung-Rong Yen; Tullia C. Bruno; Nicholas M. Durham; Edward L. Hipkiss; Kristin J. Pyle; Satoshi Wada; Fan Pan; Drew M. Pardoll; Charles G. Drake, MOLECULAR IMMUNOLOGY, 47(7-8):1595 - 1600, Apr. 2010
• Tc17 CD8 T Cells: Functional Plasticity and Subset Diversity, Hung-Rong Yen; Timothy J. Harris; Satoshi Wada; Joseph F. Grosso; Derese Getnet; Monica V. Goldberg; Kai-Li Liang; Tullia C. Bruno; Kristin J. Pyle; Siaw-Li Chan; Robert A. Anders; Cornelia L. Trimble; Adam J. Adler; Tzou-Yien Lin; Drew M. Pardoll; Ching-Tai Huang; Charles G. Drake, JOURNAL OF IMMUNOLOGY, 183(11):7161 - 7168, Dec. 2009
• Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model., Satoshi Wada; Kiyoshi Yoshimura; Edward L Hipkiss; Tim J Harris; Hung-Rong Yen; Monica V Goldberg; Joseph F Grosso; Derese Getnet; Angelo M Demarzo; George J Netto; Robert Anders; Drew M Pardoll; Charles G Drake, Cancer research, 69(10):4309 - 18, May 2009
• Tumor Recognition and Self-Recognition Induce Distinct Transcriptional Profiles in Antigen-Specific CD4 T Cells, Derese Getnet; Charles H. Maris; Edward L. Hipkiss; Joseph F. Grosso; Timothy J. Harris; Hung-Rong Yen; Tullia C. Bruno; Satoshi Wada; Adam Adler; Robert W. Georgantas; Chunfa Jie; Monica V. Goldberg; Drew M. Pardoll; Charles G. Drake, JOURNAL OF IMMUNOLOGY, 182(8):4675 - 4685, Apr. 2009
• Radiotherapy augments the immune response to prostate cancer in a time-dependent manner, Timothy J. Harris; Edward L. Hipkiss; Scott Borzillary; Satoshi Wada; Joseph F. Grosso; Hun-Rong Yen; Derese Getnet; Tullia C. Bruno; Monica V. Goldberg; Drew M. Pardoll; Theodore L. DeWeese; Charles G. Drake, PROSTATE, 68(12):1319 - 1329, Sep. 2008
• Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1, Hidenobu Ishizaki; Takuya Tsunoda; Satoshi Wada; Mai Yamauchi; Masabumi Shibuya; Hideaki Tahara, CLINICAL CANCER RESEARCH, 12(19):5841 - 5849, Oct. 2006
• Development of anti-angiogenic cancer vaccine using epitope peptides derived from vascular endothelial growth factor receptor 1 (VEGFR1), Hidenobu Ishizaki; Takuya Tsunoda; Satoshi Wada; Masabumi Shibuya; Hideaki Tahara, CANCER RESEARCH, 66(8), Apr. 2006
• Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2., Satoshi Wada; Takuya Tsunoda; Toshiyuki Baba; F James Primus; Hiroyuki Kuwano; Masabumi Shibuya; Hideaki Tahara, Cancer research, 65(11):4939 - 46, Jun. 2005
• Ring finger protein 43 as a new target for cancer immunotherapy., Naotaka Uchida; Takuya Tsunoda; Satoshi Wada; Yoichi Furukawa; Yusuke Nakamura; Hideaki Tahara, Clinical cancer research : an official journal of the American Association for Cancer Research, 10(24):8577 - 86, Dec. 2004
• Carcinoid of the Papilla of Vater; A case report, H Suzuki; H Kuwano; N Masuda; K Tuboi; S Wada; T Saitoh; K Kanoh; K Nomoto; T Shimura, HEPATO-GASTROENTEROLOGY, 50(50):371 - 373, Mar. 2003

Presentations

• 抗PD-1抗体で発症せず、抗PD-L1抗体投与後に血球貪食症候群様の免疫関連有害事象を発症した肺癌症例, 有泉　裕嗣;吉村　清;堀池　篤;平澤　優弥;石黒　智之;大熊　遼太朗;久保田　祐太郎;濵田　和幸;和田　聡;鶴谷　純司;角田　卓也, 第25回日本がん免疫学会総会, 03 Jul. 2021, 和歌山
• 転移前微小環境形成における交感神経の機能解析, 家口　勝昭;大熊　遼太朗;辻　まゆみ;木内　祐二;角田　卓也;小林　真一;和田　聡, 第25回日本がん免疫学会総会, 01 Jul. 2021, 和歌山
• Expression of Olfactomedin-4 in pancreatic cancer and its clinical significance, OKUMA Ryotaro;KUBOTA Yutaro;HAMADA Kazuyuki;ISHIDA Hiroo;HIRASAWA Yuya;ARIIZUMI Hirotsugu;SATOH Etsuko;SHIDA Midori;WATANABE Makoto;TSURUTANI Junji;YOSHIMURA Kiyoshi;AOKI Takeshi;MURAKAMI Masahiko;NOROSE Tomoko;OHIKE Nobuyuki;TAKIMOTO Masafumi;TSUNODA Takuya;WADA Satoshi, 第17回日本臨床腫瘍学会学術集会 (JSMO 2019), 18 Jul. 2019, 京都